UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration

World journal of gastroenterology : WJG, 2016-05, Vol.22 (19), p.4732-4740

2016

Volltextzugriff (PDF)

Drug rechallenge following drug‐induced liver injury

Hepatology (Baltimore, Md.), 2017-08, Vol.66 (2), p.646-654

2017

Volltextzugriff (PDF)

Characterizing phenotypes and outcomes of drug-associated liver injury using electronic medical record data

Pharmacoepidemiology and drug safety, 2013-02, Vol.22 (2), p.190-198

2013

Volltextzugriff (PDF)

Assessment of the Frequency, Phenotypes, and Outcomes of Acute Liver Injury Associated with Amoxicillin/Clavulanate in 1.4 Million Patients in the Veterans Health Administration

Drug safety, 2023-02, Vol.46 (2), p.129-143

2023

Volltextzugriff (PDF)

Medications Associated with Lower Mortality in a SARS-CoV-2 Positive Cohort of 26,508 Veterans

Journal of general internal medicine : JGIM, 2022-12, Vol.37 (16), p.4144-4152

2022

Volltextzugriff (PDF)

Children's liver chemistries vary with age and gender and require customized pediatric reference ranges

Regulatory toxicology and pharmacology, 2015-10, Vol.73 (1), p.349-355

2015

Volltextzugriff (PDF)

Co-medications That Modulate Liver Injury and Repair Influence Clinical Outcome of Acetaminophen-Associated Liver Injury

Clinical gastroenterology and hepatology, 2009-08, Vol.7 (8), p.882-888

2009

Volltextzugriff (PDF)

Implementation of Pharmacogenetic Testing Within the Veterans Health Administration From 2011 to 2013

Military medicine, 2016-10, Vol.181 (10), p.1375-1381

2016

Volltextzugriff (PDF)

Drug-induced liver injury following positive drug rechallenge

Regulatory toxicology and pharmacology, 2009-06, Vol.54 (1), p.84-90

2009

Volltextzugriff (PDF)

Validation of Multivariate Outlier Detection Analyses Used to Identify Potential Drug-Induced Liver Injury in Clinical Trial Populations

Drug safety, 2012-10, Vol.35 (10), p.865-875

2012

Volltextzugriff (PDF)

Background incidence of liver chemistry abnormalities in pediatric clinical trials for conditions with and without underlying liver disease

Regulatory toxicology and pharmacology, 2012-03, Vol.62 (2), p.329-335

2012

Volltextzugriff (PDF)

The evaluation of drug rechallenge: The casopitant Phase III program

Regulatory toxicology and pharmacology, 2010-12, Vol.58 (3), p.539-543

2010

Volltextzugriff (PDF)

Background incidence of liver chemistry abnormalities in a clinical trial population without underlying liver disease

Regulatory toxicology and pharmacology, 2008-11, Vol.52 (2), p.85-88

2008

Volltextzugriff (PDF)

Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria

The American journal of gastroenterology, 1999-05, Vol.94 (5), p.1279-1282

1999

Volltextzugriff (PDF)

Hepatitis C in pregnancy

Obstetrics and gynecology (New York. 1953), 1997-05, Vol.89 (5 Pt 2), p.883-890

1997

Volltextzugriff (PDF)

Tolerability and safety of alosetron during long-term administration in female and male irritable bowel syndrome patients

The American journal of gastroenterology, 2001-03, Vol.96 (3), p.803-811

2001

Volltextzugriff (PDF)

Liver disease in pregnancy

American family physician, 1999-02, Vol.59 (4), p.829-836

1999

Volltextzugriff (PDF)

Alterations in colonic mucosal vessels in patients with cirrhosis and noncirrhotic portal hypertension

Human pathology, 1998-05, Vol.29 (5), p.527-535

1998

Volltextzugriff (PDF)

Evaluation of a workplace hemochromatosis screening program

American journal of preventive medicine, 1999-05, Vol.16 (4), p.303-306

1999

Volltextzugriff (PDF)

Medical problems occurring after orthotopic liver transplantation

Digestive diseases and sciences, 1997-08, Vol.42 (8), p.1666-1674

1997

Volltextzugriff (PDF)

Hepatic cytochrome P-4503A (CYP3A) activity in the elderly

Mechanisms of ageing and development, 1992-06, Vol.64 (1), p.189-199

1992

Volltextzugriff (PDF)

Combined factor IX and XI deficiency discovered at liver biopsy

Digestive diseases and sciences, 1997-08, Vol.42 (8), p.1731-1733

1997

Volltextzugriff (PDF)

Effect of orthotopic liver transplantation on employment and health status

Liver Transplantation and Surgery, 1996-03, Vol.2 (2), p.148-153

1996

Volltextzugriff (PDF)

Effect of interferon-α treatment of chronic hepatitis C on health-related quality of life

Digestive diseases and sciences, 1997-12, Vol.42 (12), p.2482-2486

1997

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(95)

Sprache

Englisch
(95)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration

Drug rechallenge following drug‐induced liver injury

Characterizing phenotypes and outcomes of drug-associated liver injury using electronic medical record data

Assessment of the Frequency, Phenotypes, and Outcomes of Acute Liver Injury Associated with Amoxicillin/Clavulanate in 1.4 Million Patients in the Veterans Health Administration

Medications Associated with Lower Mortality in a SARS-CoV-2 Positive Cohort of 26,508 Veterans

Children's liver chemistries vary with age and gender and require customized pediatric reference ranges

Co-medications That Modulate Liver Injury and Repair Influence Clinical Outcome of Acetaminophen-Associated Liver Injury

Implementation of Pharmacogenetic Testing Within the Veterans Health Administration From 2011 to 2013

Drug-induced liver injury following positive drug rechallenge

Validation of Multivariate Outlier Detection Analyses Used to Identify Potential Drug-Induced Liver Injury in Clinical Trial Populations

Background incidence of liver chemistry abnormalities in pediatric clinical trials for conditions with and without underlying liver disease

The evaluation of drug rechallenge: The casopitant Phase III program

Background incidence of liver chemistry abnormalities in a clinical trial population without underlying liver disease

Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria

APOL1 Risk Variants, Acute Kidney Injury, and Death in Participants With African Ancestry Hospitalized With COVID-19 From the Million Veteran Program

Hepatitis C in pregnancy

Tolerability and safety of alosetron during long-term administration in female and male irritable bowel syndrome patients

Liver disease in pregnancy

Alterations in colonic mucosal vessels in patients with cirrhosis and noncirrhotic portal hypertension

Evaluation of a workplace hemochromatosis screening program

Medical problems occurring after orthotopic liver transplantation

Hepatic cytochrome P-4503A (CYP3A) activity in the elderly

Combined factor IX and XI deficiency discovered at liver biopsy

Effect of orthotopic liver transplantation on employment and health status

Effect of interferon-α treatment of chronic hepatitis C on health-related quality of life

Aktive Filter

Suchergebnisse filtern